Autres langues Kezar Life Sciences, Inc.

Actions

KZR

US49372L1008

Temps réel estimé Cboe BZX Autres places de cotation 20:40:57 17/07/2024			Varia. 5j.	Varia. 1 janv.
0,702 ^USD	+7,98 %		+23,33 %	-26,17 %

09/05	Kezar Life Sciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
14/03	Kezar Life Sciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

KEZAR ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(4)	11/07
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	10/07
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	07/06
Kezar Life Sciences : Failure to Satisfy Listing Rule Form 8 K	04/06
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference	29/05
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
Kezar Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	06/05
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	08/04
Kezar Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update	14/03
Kezar Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	08/03
Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference	28/02
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis	27/02
Kezar Life Sciences, Inc.(NasdaqGS:KZR) dropped from NASDAQ Biotechnology Index	15/12
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)	04/12
Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference	21/11
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update	13/11
Kezar Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kezar Life Sciences, Inc.

Actions

KZR

US49372L1008

Autres langues

Filtres